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Abstract
Alternative splicing (AS) has the potential to greatly expand the functional repertoire of mammalian transcriptomes.
However, few variant transcripts have been characterized functionally, making it difficult to assess the contribution of AS
to the generation of phenotypic complexity and to study the evolution of splicing patterns. We have compared the AS of
309 protein-coding genes in the human ENCODE pilot regions against their mouse orthologs in unprecedented detail,
utilizing traditional transcriptomic and RNAseq data. The conservation status of every transcript has been investigated,
and each functionally categorized as coding (separated into coding sequence [CDS] or nonsense-mediated decay [NMD]
linked) or noncoding. In total, 36.7% of human and 19.3% of mouse coding transcripts are species specific, and we observe
a 3.6 times excess of human NMD transcripts compared with mouse; in contrast to previous studies, the majority of
species-specific AS is unlinked to transposable elements. We observe one conserved CDS variant and one conserved NMD
variant per 2.3 and 11.4 genes, respectively. Subsequently, we identify and characterize equivalent AS patterns for 22.9% of
these CDS or NMD-linked events in nonmammalian vertebrate genomes, and our data indicate that functional NMD-
linked AS is more widespread and ancient than previously thought. Furthermore, although we observe an association
between conserved AS and elevated sequence conservation, as previously reported, we emphasize that 30% of conserved AS
exons display sequence conservation below the average score for constitutive exons. In conclusion, we demonstrate the value
of detailed comparative annotation in generating a comprehensive set of AS transcripts, increasing our understanding of AS
evolution in vertebrates. Our data supports a model whereby the acquisition of functional AS has occurred throughout
vertebrate evolution and is considered alongside amino acid change as a key mechanism in gene evolution.
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Introduction
The majority of human genes are subject to alternative
splicing (AS) (Harrow et al. 2006; Tress et al. 2007; Kim
et al. 2008; Wang et al. 2008; Chen and Manley 2009).
AS occurs in invertebrate, plant, and fungal genomes
(Cheah et al. 2007; McGuire et al. 2008; Hansen et al.
2009; Simpson et al. 2010), although its higher frequency
in vertebrates suggests a link with phenotypic complexity
(Kim et al. 2007). However, the vast majority of AS tran-
scripts identified in the human genome lack described
functions, and it is now clear that AS does not simply
act to generate protein isoforms. Notably, the introduction
of a premature termination codon (PTC) can induce the
nonsense-mediated decay (NMD) pathway, causing the
degradation of the transcript (Mendell et al. 2004). It
has been suggested that the majority of AS in human
may not generate protein isoforms (Sorek et al. 2004;
Skandalis et al. 2010) and that AS may play a significant
role in gene regulation (Lewis et al. 2003; Skandalis et al.
2010). In fact, 60% of AS transcripts characterized in the
ENCODE project pilot phase lacked annotated CDS (Tress
et al. 2007).
Because the demonstration of AS functionality in the lab-
oratory is a low-throughput endeavor, attempts to study ge-
nome-wide AS must rely on in silico methods using proxies for
functionality. Recently, several such analyses have uncovered
trends inAS bystudying de novo alignments of transcriptional
data or existing computational genebuilds. Notably, human
splicing patterns are frequently seen to correlate with tis-
sue-specific expression profiles (Wang et al. 2008), and both
tissue-specific AS exons and those conserved between human
and mouse typically display elevated sequence conservation
(Sorek andAst 2003;Korenetal.2007; Wangetal. 2008).Tissue
specificity and sequence conservation are thus markers of AS
functionality, although the mechanistic relationship between
sequence conservation and AS remains unclear. Nevertheless,
the major portion of human AS appears to be species specific,
and it is clear that transposable elements (TEs) have played
a significant role in the creation of new exons (Sorek et al.
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2002;Amit etal. 2007;Sela etal.2007; Gal-Marketal.2008; Ram
et al. 2008; Schwartz et al. 2009; Sela et al. 2010). However, in
this context, the definition of ‘‘functionality’’ becomes looser
becausenewtranscriptsare likelytoremainselectivelyneutral,
while they are ‘‘tested’’ for functionality (Modrek and Lee
2003). Furthermore,the linkbetween transcriptionaland phe-
notypic complexity is unfortunately obscured by practical
considerations; nucleotide entries in databases such as Gen-
Bank contain sequencing errors (Benson et al. 2010), whereas
transcript librariescontain ‘‘noise,’’ forexample,objects result-
ing from in vivo splicing errors. All these may cause false inter-
pretations(Graveley2001;Soreketal.2004; Pickrelletal.2010).
In this study, we compare the AS repertoire of 309 human
coding genes within the 44 ENCODE pilot regions against
their mouse orthologs in a systematic manner, using con-
servation as an indicator of functionality; essentially, we de-
scribe the AS complement of a smaller genomic region
(approximately 30 Mb) to an unprecedented level of detail.
We demonstrate that the description of AS based on inten-
sive manual annotation results in a significant gain of infor-
mation, increasing AS coverage while providing greater
insights into the functionality of each transcript. Our manual
annotation is recognized as more accurate than computa-
tional methods in creating gene models; we provided the ref-
erence gene annotation for the ENCODE pilot regions and
are now annotating the whole human genome as part of
the GENCODE consortium (Guigo et al. 2006; Harrow
et al. 2006; Wilming et al. 2008). This methodology is partic-
ularly suited to the identification of spurious transcripts and
judgesthe codingpotentialofeach validspliceformona case-
by-case basis. By annotating human and mouse in tandem,
we distinguish transcripts that are conserved in both species
from those that are species specific. In addition, we utilize
RNAseq data sets to validate human and mouse models that
could initially be constructed based on transcriptional data
from the other species due to spice site conservation,
whereas a subset of such human models are also confirmed
using reverse transcriptase–polymerase chain reaction (RT-
PCR). We judge the age of our conserved splicing events by
a comparison with nonmammalian genomes, primarily the
manually annotated zebrafish genome. We also examine the
sequence-level conservation of our AS events and the extent
to which these exons overlap with TEs. Overall, our data set
provides a highly informative assessment of the evolution of
AS patterns in vertebrates, in particular regarding the poten-
tial role of NMD in functional splicing.
Materials and Methods
Genome Annotation
We had previously annotated the ENCODE pilot phase
regions of the human reference genome, which approxi-
mates to 1% of the assembly (Harrow et al. 2006). These
regions were originally selected to help develop methods
for the identification of functional genome elements in
a community-wide manner (Birney et al. 2007). Approxi-
mately 15 Mb of this sequence was selected manually, target-
ing genomic regions of known biological interest, whereas
the other 15 Mb was selected using a stratified random
approach; further information is provided in supplementary
file 1 (Supplementary Material online). For this study, the ex-
isting gene models in GRCh37/hg19 were reexamined and
updated as appropriate. Mouse regions orthologous to
the 44 pilot sections were available from the ENCODE con-
sortium, and genes were annotated in tandem with their hu-
man counterparts using the annotation criteria of the Vega
project (Wilming et al. 2008). These detailed criteria are dis-
cussed in supplementary file 1 (Supplementary Material on-
line). Briefly, this process uses in-house software and is based
on the genomic alignment of multispecies transcriptional
(expressed sequence tags [ESTs], mRNAs, and cDNAs)
and protein evidence in GenBank and UniProt. Canonical
splice sites were required for the construction of splice junc-
tions. Transcript models were annotated as noncoding (in-
cluding nonpolyadenylated retained introns, which cannot
be distinguished from immature transcripts), CDS linked, or
NMD linked. The putative annotation of NMD required
the presence of an in-frame termination codon located 50
bp or more upstream of a splice junction (this is standard
in NMD classification [Lewis et al. 2003]). Interspersed repeats
overlapping with gene models were identified firstly as part of
a standard RepeatMasker analysis included in the Vega anno-
tation pipeline (Smit et al. 1996–2010) and secondly by que-
rying the RepBase data set (Jurka et al. 2005). Zebrafish loci
orthologous to human and mouse genes were identified using
the orthology resources at ZFIN (Sprague et al. 2006); these
assignments were manually queriedusing the VertebrateMul-
tiz Alignment and Conservation resources at the UCSC
genome browser (Siepel et al. 2005; Pollard et al. 2010). Zebra-
fish annotation was performed using the same essential meth-
odology as for human and mouse (Jekosch 2004), making
additionaluseofRNAseqgenemodelsconstructedbyS.White
based on in house paired end data generated on the Illumina
Genome Analyzer platform (see Ensembl release 59).
Analysis of Alternative Splicing Conservation
Exonic and intronic sequences from human and mouse were
extracted, aligned, and compared using in-house software
based on the Ensembl Compara API (a multispecies database
containing the results of genome-wide species comparisons
[Hubbard et al. 2009]). Alignments between human and ze-
brafish exons were performed individually using ClustalW
(Larkin et al. 2007), with exonic orthology being assigned dur-
ing the annotation process. Conservation in non-Vega anno-
tated genomes was examined using the Vertebrate Multiz
Alignment and Conservation resources at the UCSC genome
browser (Siepel et al. 2005; Pollard et al. 2010), in conjunction
with independent Blast analyses (Altschul et al. 1990) against
the relevant genome using the human AS exon and flanking
exons. Transcriptional support for AS events in such ge-
nomes was established using the UCSC genome browser.
Two-tailed z-tests were used for statistical testing.
RNAseq Analysis
Complications remain in performing the de novo alignment
of RNAseq reads to genomic sequence (Morin et al. 2008;
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Mortazavi et al. 2008; Wang et al. 2009); hence, the anno-
tation process began by extracting the maximum informa-
tion from the traditional transcriptomics and proteomics
databanks. Subsequently, each object based entirely on ev-
idence from another species was used to query RNAseq
libraries in an attempt to provide species-specific support.
For human, this was the library generated by Wang et al.
(2008); for mouse, the library generated by Mortazavi et al.
(2008). The RNAseq reads were mapped using GEM
(http://gemlibrary.sourceforge.net), allowing up to two
mismatches against a combined index including the corre-
sponding genome sequence and annotated splice junctions.
In each case, the alignments of the supporting reads were
manually reanalyzed, and ambiguous matches were rejected
(e.g., matches with more than one equivalent genome loca-
tion). Human models based on mouse evidence were also
validated against human RNAseq models generated by S.
White at Ensembl, using an Exonerate-based methodology
(Slater and Birney 2005) for the RNAseq Genome Annota-
tion Assessment Project 1; information on the libraries used
is presented at http://gencodegenes.org/rgasp.
RT-PCR Analysis
Each human transcript based on mouse evidence was sub-
jected to RT-PCR validation. Double-stranded cDNA from
eight human tissues (brain, heart, kidney, testis, liver,
spleen, lung, skeletal muscle) was generated with the Mar-
athon cDNA amplification kit (Clontech). Flanking primer
pairs were designed to specifically target in human the AS
form identified in mouse. Primer sequences are included in
supplementary file 2 (Supplementary Material online). The
PCRs were performed with JumpStart REDTaq ReadyMix
(Sigma). For each tissue, 2 ll of each RT-PCR reaction were
pooled together (a total of 760 reactions, the majority of
which were not related to the present study) and purified
with the QIAquick PCR purification Kit (QIAGEN). This pu-
rified DNA was used to generate a sequencing library with
the ‘‘Genomic DNA sample prep kit’’ (Illumina) according
to the manufacturer’s recommendations, minus the frag-
mentation step. This library was subsequently sequenced
on an Illumina Genome Analyzer 2 platform. The 75-bp
reads were mapped onto both the reference human ge-
nome (hg19) and the predicted spliced amplicons using
bowtie 0.12.5 (Langmead et al. 2009). Uniquely mapping
reads with no mismatch were used to validate splice sites.
Splice junctions were validated if spanned by a minimum of
10 reads with a minimum of 8 nucleotides flanking the
breakpoints.
Results and Discussion
Generation of the AS Data Set
Human and Mouse Gene Annotation
We defined 309 pairs of orthologous protein-coding genes in
the human and mouse genomes; these are listed in supple-
mentary file 2 (Supplementary Material online). Table 1 cat-
egorizes each individual transcript constructed for these
gene pairs based on its conservation status and functional
annotation. Transcripts are divided into: ‘‘conserved’’ tran-
scripts supported by equivalent transcriptional evidence in
both species, human and mouse specific transcripts (collec-
tively referred to as ‘‘species specific’’), and transcripts built in
one species using mRNAs or ESTs from the other on the basis
of splice site and reading frame conservation (‘‘cross-species
transcripts,’’ separated into ‘‘human to mouse’’ and ‘‘mouse
to human’’). Finally, the ‘‘status change’’ category includes
a small number of transcripts that were not added cross-spe-
cies in spite of splice site conservation because their coding
category would have been changed. Further analysis is lim-
ited to coding transcripts (i.e., CDS and NMD), and redun-
dancy due to untranslated region (UTR) variation was
eliminated; analysis of conserved AS in UTRs is complicated
by the decoupling of functional and positional conservation
in vertebrate promoter regions (Birney et al. 2007; Schmidt
et al. 2010).
Classification of Human and Mouse AS
For each locus we classified, a ‘‘reference’’ transcript against
which AS events could be compared (essentially the con-
served CDS transcript with the most transcriptional sup-
port; see supplementary file 1, Supplementary Material
online). Supplementary file 3 (Supplementary Material on-
line) divides the AS transcripts from table 1 into 68 cate-
gories based on their structure and coding annotation
(henceforth referred to as ‘‘biotypes’’), considering only
the nature of the AS event of interest and not the whole
transcript (this creates the small differences in total counts
seen between the two data sets; see supplementary file 1,
Supplementary Material online). Subsequent analysis is
limited to the two major biotype categories presented
Table 1. Total Transcripts Built within 309 Pairs of Orthologous Human and Mouse Protein Coding Loci
Human Coding Noncoding NMD CDS Conserved Hs specific Cross-species Hs Status change Cross-species Mm
Total 1,675 1,049 324 1,351
Nonredundant 1,264 424 464 260 15 101
NMD 288 22 146 89 4 27
CDS 976 402 318 171 11 74
Mouse Coding Noncoding NMD CDS Conserved Mm specific Cross-species Mm Status change Cross-species Hs
Total 1,207 748 193 1,014
Nonredundant 979 424 189 101 5 260
NMD 180 22 41 27 1 89
CDS 799 402 148 74 4 171
NOTE.—Hs, human; Mm, mouse; cross-species Hs, added to mouse based on human evidence; cross-species Mm, added to human based on mouse evidence; status change,
cross-species transcripts with conserved splice sites though nonconserved CDS/NMD annotation. Gray shading highlights transcripts supported by evidence in that species.
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in figure 1: interior modifications, representing splice site
shifts and single cassette exons (cassettes) that are flanked
by coding exons present in the reference transcript, and
terminal modifications, where a new or modified terminal
coding exon is linked to a variant CDS. Multi-cassettes are
thus ignored in subsequent calculations unless stated;
these cassettes combine to generate the final coding cat-
egory and are low in number.
Validation of Cross-Species Transcripts
We identified 134 conserved AS events based on our initial
use of traditional transcriptomics data. Table 1 and figure 1
also incorporate RNAseq and RT-PCR data. First, our
RNAseq analysis using existing libraries provided support
for 9 human transcripts initially based on mouse mRNAs
or ESTs and 12 mouse transcripts initially based on hu-
man evidence (see Materials and Methods). Second, we
provided support for three additional human transcripts
by comparison to RNAseq gene models produced by
the Ensembl group (S. White, unpublished data). Finally,
we validated a further four mouse-supported AS events
in human via RT-PCR (see Materials and Methods). Overall,
we reclassified 28 AS events as supported in both species,
giving 162 events in total. This 20.9% increase demonstrates
the value of comparative annotation in predicting AS
events for validation and confirms that existing EST and
mRNA databases for human and mouse are nonsaturated.
Analysis of Species-Specific Splicing
The Human Data Set Contains More AS Transcripts than
Found in Mouse
Considering all data in table 1, we have annotated 769 more
transcripts in human than in mouse; human contains an
extra 1.0 noncoding transcripts and 1.5 coding transcripts
FIG. 1. Summary of interior and terminal modification alternative splicing biotypes. This figure summarizes the most common biotype
categories in the data set (interior and terminal modifications); a complete set of 68 biotypes is represented in supplementary file 3
(Supplementary Material online). The total numbers highlighted in blue relate to the full 68 biotypes, whereas the total numbers of AS event
within each biotype category are highlighted within the gray bars. Each entry represents the categorization of a particular AS event described
within the context of the reference transcript structure and not the complete transcript itself; for this reason, the total counts differ slightly
from those in table 1 (see supplementary file 1, Supplementary Material online, for further information). From left to right, ‘‘conserved Hs/Mm’’
lists events supported in human and mouse, ‘‘Hs-specific’’ and ‘‘Mm-specific’’ events that are species specific, ‘‘cross sp. Hs’’ and ‘‘cross sp. Mm’’
events that could be aligned cross-species, and ‘‘conserved non-mam.’’ events for which AS is also supported in nonmammals (this is thus
a subset of ‘‘conserved Hs/Mm’’; see supplementary file 2, Supplementary Material online). Although cassette events are pictorially represented
by the insertion of an additional exon, these categories also include the ‘‘skipping’’ of exons from the reference transcript. Cassette counts do
not include multiple exon events or mutually exclusive exon pairs. For splice site shifts, the counts for shifts in both the 5# and 3# directions
have been combined. Furthermore, these counts do not distinguish between alternative STOPs and PTCs found within the AS region and those
that appear downstream out of frame with the reference CDS. In all cases, these biotypes are distinguished in supplementary file 3
(Supplementary Material online).
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per gene. However, the Expressed Sequence Tags database
contains approximately 1.7 times as many human ESTs as
mouse (Boguski et al. 1993), and the detection of AS levels
is related to EST coverage (Kan et al. 2002; Kim et al. 2004,
2007). Although the total transcript counts cannot be in-
terpreted with confidence, a comparison of the CDS to
NMD ratios in each species may be informative. Supple-
mentary file 4 (Supplementary Material online) summa-
rizes the CDS and NMD transcripts highlighted in gray
in table 1 as a Venn diagram, thus considering for both spe-
cies only transcripts supported by evidence from that spe-
cies. We observe a higher proportion of NMD transcripts in
human: 22.4% of the 1,163 human supported coding tran-
scripts are NMD, compared with 12.7% of the 719 mouse
supported. These values suggest an increase in NMD-linked
transcription in human, although we cannot eliminate the
possibility that they are affected by inconsistencies in the
creation of the various human and mouse EST libraries. Fig-
ure 1 indicates that the excess of human NMD transcripts is
largely explained by a similar excess of cassettes; 61.5% of
the 174 NMD events in the human-specific and added
cross-species to mouse categories are linked to single cas-
settes, whereas there are 3.8 times as many cassette events
in these categories as in their mouse equivalents. Here, we
define cassette events as whole exon exclusions (skips) or
insertions; cassettes that generate alternative CDS are re-
ferred to as ‘‘CDS cassettes’’ and those predicted to induce
the NMD pathway as ‘‘NMD cassettes.’’ Exon skipping has
been reported as the prevalent form of AS in metazoans
(Kim et al. 2007). However, human cassette events do
not induce NMD at a higher frequency compared with
mouse; 68.4% and 69.0% of the respective species-specific
cassettes are NMD cassettes.
AS Exons Are Formed from Transposable Elements and
Noncoding Sequence in Human and Mouse
AS in human has been linked to the expansion of Alu el-
ements in the genome, and such elements are absent in
mouse (Sorek et al. 2002; Amit et al. 2007; Sela et al.
2007; Gal-Mark et al. 2008; Ram et al. 2008; Schwartz
et al. 2009; Sela et al. 2010). Furthermore, the exonization
of TEs has been reported as more widespread in the human
genome compared with mouse (Sela et al. 2007). We thus
examined the association between species-specific AS
events and TEs in our data set; these data are presented
in supplementary file 2 (Supplementary Material online).
If the excess of human cassettes is linked to TEs, we would
expect a similar excess in the proportion of cassettes over-
lapping TE sequences. Each species-specific cassette event
represents an insertion; a human skip will inevitably be
added to mouse provided the flanking exons are present
in both species. We observe that 49.2% of human-specific
NMD cassettes overlap with TEs (typically Alus), compared
with 45.0% in mouse. The respective values for CDS cas-
settes are 40.0% and 33.3%. The two species also possess
comparable rates of TE association in the terminal modi-
fication biotypes. For example, 21.3% of alternative first
coding exons and 46.7% of alternative final coding exons
overlap with TEs in human, compared with 23.1% and
55.6%, respectively, in mouse. In contrast, we observe
a lower association between TEs and splice site shifts; of
the total 75 human and mouse-specific shifts that extend
into intronic sequence, only 6 overlap with TEs. In sum-
mary, the exonization of TEs apparently does not explain
any human excesses in the major biotypes categories; hu-
man possesses similar excesses in the proportions of events
that are not linked to TEs.
However, although the majority of species-specific AS
events appear unlinked to TEs, some may have formed from
TEs whose sequences have degraded past the point of rec-
ognition. Alternately, a species-specific AS event may actu-
ally signify a loss of function in the reciprocal species, for
example, the degradation of splicing capability. However,
we do not detect convincing genomic or transcriptomic ev-
idence for the existence of any human or mouse-specific AS
events prior to the formation of the rodent/primate clade
(data not shown). Finally, new AS events may have been cre-
ated by localized exonic duplication; again, we see no evi-
dence for this within our data set (data not shown).
Instead, we infer on the basis of parsimony that AS creation
unlinked to TEs is largely due to the exonization of intronic or
nongenic sequence, presumably where splicing motifs are
created by point mutation. In summary, our analysis indi-
cates that TEs and non-transposon sequence play similarly
important roles in the creation of new AS events in the hu-
man and mouse genomes.
Analysis of AS Conserved between Human and
Mouse
Gene Regulation by NMD Is Widespread in the Human and
Mouse Genomes
Our 162 conserved AS events represent one CDS transcript
per 2.3 genes, and one NMD transcript per 11.4 genes; these
events are contained within 95 out of 309 genes (supplemen-
tary files 2 and 3, Supplementary Material online). Consid-
ering all 68 AS biotypes in supplementary file 3
(Supplementary Material online), the cassette is the most
common AS form conserved between human and mouse
(48.8%). Furthermore, although 68.4% of human-specific sin-
gle cassettes are NMD cassettes, 76.1% of conserved single
cassette events are CDS cassettes (fig. 1), supporting an as-
sumption that functional AS chiefly acts to generate protein
isoforms. Nonetheless, our identification of conserved NMD
is interesting, although not unprecedented. It has been re-
ported that most mammalian NMD transcripts are not un-
der selective pressure and therefore likely to be noise (Pan
et al. 2006). However, members of the SR (serine–arginine)
family of splicing factors use NMD isoforms to downregulate
their own translation in a homeostatic manner, and it is spec-
ulated that this strategy (regulated unproductive splicing
and translation or ‘‘RUST’’) may be common to splicing fac-
tors generally (Sureau et al. 2001; Lareau et al. 2007). We have
identified 27 NMD-inducing AS events that are conserved
between human and mouse. Of these 27, RBM39, SF1,
SON, and LUC7L have demonstrated or putative roles as
splicing factors. Although these four genes are not
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categorized as SR proteins, we predict that they may be sub-
ject to RUST. Although functional information is not avail-
able for all the remaining 23 genes, most do not appear to
function in splicing; PISD, for example, is involved in the for-
mation of phosphatidylethanolamine. Our analysis there-
fore suggests that RUST may be a widespread mechanism,
not limited to particular gene families.
Conserved AS Events Can Be Formed from Transposon
Sequence
Two of the 162 conserved AS events are linked to TEs, in-
dicating that exons created by this mechanism may acquire
genuine functionality (see supplementary file 5, Supple-
mentary Material online). First, the splice acceptor site
and CDS portion of an alternative final exon of the OBSL1
gene are contained within a CHARLIE8 element, a mam-
mal-specific TE (Jurka et al. 2005). The splice site and intact
CDS are found in all placental mammal genomes for which
sequence is available, and the absence of the STOP codon
in the TE consensus sequence suggests a gain of function
mutation. The most divergent alignment identified is to the
opossum genome, where sequence conservation is weaker
and the CDS disrupted. Second, a 69-bp cassette of the ST7
gene is embedded within an L3 element. This exon is 100%
identical between human and mouse at the sequence level;
it is in fact 99–100% identical among all placental mam-
mals, although apparently absent outside eutherians. This
suggests the exon may have been rapidly subjected to pu-
rifying selection following its incorporation into the ST7
gene.
A Subset of AS Exons Display an Increase in Sequence
Conservation
It is well established that AS exons in general display ele-
vated sequence conservation, often extending into intronic
regions (Sorek and Ast 2003; Sorek et al. 2004; Koren et al.
2007). We sought to reappraise this association in the con-
text of our wider range of AS biotypes and conservation
categories. We have calculated the percentage sequence
similarity between human and mouse of each conserved
AS exon (exonic similarity scores), as well as the scores
for the 1,118 constitutive exons within these same genes
for comparison (ignoring terminal CDS exons). Similarly,
we have calculated the percentage identity of the flanking
intronic sequences in 40-bp and 100-bp windows from all
splice donor and acceptor sites for both exon sets (intronic
similarity scores). We define 95% sequence identity as our
marker for significance in the 40-bp window because below
1.5% of the total 5# and 3# flanks in the control set exceed
this value. All scores calculated for AS exons are presented
in supplementary file 2 (Supplementary Material online).
In total, 74.2% of conserved AS events represent interior
modifications; one conserved cassette event per 3.9 genes
and one conserved splice site shift per 7.5 genes (supple-
mentary file 3, Supplementary Material online). Figure 2
plots the exonic similarity scores of constitutive exons, con-
served single CDS cassettes, and conserved single NMD cas-
settes. The tendency of cassettes to be shorter than
constitutive exons has been reported (Sorek et al. 2004).
Here, 62.3% of conserved cassettes are shorter than the con-
stitutive lower quartile of 90 bp, whereas 25.9% of CDS cas-
settes are under 30 bp in size, compared with 1.0% of
constitutive cassettes. The average exonic similarity score
is 88.1 ± 5.5% for constitutive exons, and we observe signif-
icantly elevated (z-test, P , 0.001) similarities of 90.7 ±
11.1% and 91.7± 10.4% for CDS and NMD cassettes, respec-
tively. In fact, 14 of these 71 exons are 100% conserved be-
tween human and mouse, compared with 5 out of 1,118
constitutive cassettes; a 44-fold excess. In addition, 30 cas-
settes have 95% or above intronic similarity scores over one
or both 40-bp flanks, a 27.8-fold excess over the control set.
However, although our data confirm that exonic conserva-
tion, short size, and intronic conservation are general attrib-
utes of cassette-based AS, it is clear from figure 2 that none
of these attributes are universal; 29.9% of AS cassettes are
larger than the constitutive mean and 22.1% have exon sim-
ilarity scores below the constitutive mean.
Because splice site shifts affect exon edges, whole exon
conservation and exon size are not informative metrics; the
largest and smallest exons in this category are 21-bp exon
and 1,491 bp, respectively. Instead, we note that 15 out of
41 shifts associate with elevated 40-bp intronic conserva-
tion at the relevant flank (8 acceptors and 7 donors), a sim-
ilar enrichment over the constitutive set as seen for
cassette exons. Again, however, elevated sequence conser-
vation is not a universal attribute of splice site shifts. The
most striking examples of conservation are from the ENPP1
and GCFC1 genes, both of which induce NMD. For ENPP1,
the 40-bp intronic flank of the shifted splice site is 100%
identical between human and mouse. A degree of conser-
vation would be expected because the splice site is shifted
into the interior of the reference transcript exon; however,
this 40-bp region is fully conserved in the chicken, lizard,
and Xenopus genomes, that is, over synonymous and non-
synonymous codon positions. This conserved region—like
the majority of those identified here—does not appear to
have been reported by any previous whole-genome inves-
tigation, likely due to its short size coupled with the fact
that it overlaps exonic sequence. In the case of GCFC1, both
alternative splice sites are found within a 31-bp region that
is 100% identical in 43 out of 46 vertebrate genomes, in-
cluding four fish species (data not shown).
The average exonic similarity score of the 13 alternative
first exons (minus the 5# UTR) is 81.9 ± 8.1%, compared
with 90.4 ± 7.2% for the constitutive first exons. All alter-
native first exon scores fall under 95%, and we detect no
evidence for elevated intronic conservation scores. In con-
trast, six of the nine alternative final exons have exonic sim-
ilarity scores exceeding the upper standard deviation of the
average score for constitutive final exons (87.6 ± 8.4%). In
addition, six are associated with elevated intronic conser-
vation over the splice acceptor 40-bp window, compared
with 2 out of 86 constitutive final exons. Finally, we detect
no signatures of sequence conservation for final coding
exons that utilize intronic STOPs; the average exonic sim-
ilarity score is 81.1± 9.6%, with all these values falling below
95%. Although these low counts prevent a robust statistical
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analysis, our preliminary findings generally support a model
whereby elevated sequence conservation at the splice ac-
ceptor site is linked to the control of AS. In short, the incor-
poration of alternative terminal exons requires the selection
of the splice acceptor site prior to the usage of a polyadeny-
lation site, whereas alternative promoters likely control the
selection of alternative first exons. Similarly, the usage of a re-
tained intron STOP would seem to depend on the rejection
rather than selection of a splice site, followed again by poly-
adenylation. However, we emphasize the need to study ter-
minal modifications as part of a larger sample size.
Analysis of AS in Nonmammalian Genomes
A Quarter of Conserved Mammalian AS Events Occur in
Nonmammalian Genomes
We next examined the relationship between sequence con-
servation at the AS event and the age of the splicing event.
AS is not restricted to mammalian genomes; its activity is
particularly well studied in fish, Drosophila, and nematodes
(Stolc et al. 2004; Hansen et al. 2009; Graveley et al. 2010; Lu
et al. 2010; Nilsen and Graveley 2010; Ramani et al. 2011).
Initially, we focused our analysis on the zebrafish genome
and manually annotated the 89 out of 95 genes for which
orthology could be established (see Materials and Meth-
ods). We searched for further AS support in all other non-
mammalian vertebrate genomes, using a simpler database
mining approach (see Materials and Methods). In total, 31
out of 95 genes (32.6%) were seen to display conserved AS
patterns beyond mammals (i.e., there is transcriptional sup-
port for both the reference and AS events in the same ge-
nome). This represents 37 out of 162 AS events (22.9%),
including 19 described in zebrafish and 14 in Xenopus;
these data are presented in supplementary file 2 (Supple-
mentary Material online) and integrated into figure 1. This
work may underestimate the true extent of splicing con-
servation because transcriptional coverage in nonmamma-
lian genomes is less complete than in human or mouse.
AS Exons Present in Nonmammals Display Elevated
Sequence Conservation
The average exonic score for the 37 AS events supported in
human, mouse, and at least one nonmammal vertebrate
(henceforth ‘‘nonmammalian AS’’) is 93.5 ± 5.8% between
human and mouse, compared with 88.5 ± 10.1% for those
125 events where AS is supported in mouse and human
though not outside mammals (henceforth ‘‘mammal-only
AS’’). We thus detect an association between elevated con-
servation at the sequence level and nonmammalian con-
servation at the splicing level (z-test P , 0.001). Of
these 37 events, 29 are interior modifications; 10 of these
AS exons are 100% identical between human and mouse,
compared with 6 of the 92 mammal-only interior modifi-
cation AS exons (a 5.5 times enrichment). Notably, 22.2% of
conserved NMD events occur in nonmammalian genomes,
often linked to striking sequence conservation; the GCFC1
splice shift event noted above occurs in human and zebra-
fish alongside 100% regional sequence conservation be-
tween the two genomes. Five other genes undergo
NMD-linked AS in nonmammals, including all four splicing
factors discussed above: SON, SF1, RBM39, and LUC7L. We
therefore demonstrate that the conservation of NMD-
linked AS in splicing factors can extend far beyond the
mammalian order. However, GCFC1 has a postulated role
in transcriptional regulation via DNA binding, whereas the
remaining gene CTTNBP2 associates with the actin
FIG. 2. The percent identity of human and mouse AS cassette exons plotted against exon size. Only AS single cassette events that are
transcriptionally supported in both species are included. ‘‘% exonic similarity’’ represents the percentage similarity of each orthologous AS
cassette pair at the base pair level. Cassettes linked to CDS are blue, whereas those linked to NMD are red. For comparison, the 1,118
constitutive internal exons for those genes displaying conserved AS are plotted in green. A cut-off of 300 bp has been used for exon size. The
vertical dotted line marks the first quartile value of the median exon size, whereas the horizontal dotted line marks the upper standard
deviation limit of the average exon percentage identity. AS cassettes linked to both CDS and NMD tend to be shorter and more similar at the
sequence level than the control exons. However, this does not hold true for all AS cassettes; for example, although 14 have exon scores of 100%,
17 fall have scores falling below the average score for the control set exons.
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cytoskeleton in rat (Ohoka and Takai 1998). Unlike for
GCFC1, we do not observe any obvious elevated conserva-
tion surrounding the alternative CTTNBP2 splice donor site.
RBM39: The Evolution of AS within a Single Gene
Our data indicate that conserved human and mouse AS
events were not created at a single point in vertebrate evo-
lution, and this statement holds true even within a single
gene. RBM39 contains significant splice variation in human
and mouse; 42 transcripts have been annotated in the former
and 24 in the latter, whereas 6 AS events are supported in
both. RBM39 is a potential splicing factor, linked to both
AS and constitutive exons (Cazalla et al. 2005); it may also
function in transcriptional regulation (Dutta et al. 2008).
However, to our knowledge the differential functionality
of individual RBM39 transcripts remains unstudied. Four
conserved AS events of particular interest are depicted in
figure 3. This includes two NMD cassettes containing PTCs
(poison exons), the first of which is 98.6% identical between
human and Xenopus (fig. 3a), and 69.9% identical between
human and zebrafish (where it also displays AS). However,
although the second NMD cassette is 99–100% identical
among all mammalian genomes, it cannot be aligned to non-
mammalian genomes (fig.3b); it appears to represent a more
recent evolutionary innovation. Although we can predict
that RBM39 is subject to RUST, the fact that this gene utilizes
two distinct poison exons in mammals raises the possibility
that the two transcripts are generated under the control of
distinct regulatory processes. Further downstream, an
RBM39 exon possesses a pair of alternative splice acceptor
sites within an 80-bp region that is 100% identical between
all but three available placental mammal genomes, although
only 68.5% identical to opossum (fig.3c). Although the down-
stream site is conserved in all genomes back to Xenopus
(where AS is supported), the upstream site in only found
in placental mammals, where AS is supported in 11 species
(data not shown). This AS event is thus apparently younger
than either poison exon event. Finally, RMB39 contains an
alternative final exon in human and mouse (fig.3d), the splice
acceptor site of which is found in all placental mammal
FIG. 3. The conservation of four alternative splicing events within RBM39. The RMB39 gene for RNA binding motif protein 39 contains six AS
events conserved between human and mouse, four of which are highlighted here. The central panel shows the structure of these four splice
variants in human (5# and 3# UTRs shown in red; CDS in green; NMD region in purple) and the Phastcons conservation plot. The peripheral
panels contain genomic alignments taken initially from the conservation track resources at the UCSC genome browser (Siepel et al. 2005;
Pollard et al. 2010). Splice acceptor sites of the form [N/GT] are represented by black triangles, splice donor sites of the form [NAG] by gray
triangles, and termination codons by blue triangles. Two of the AS events are ‘‘poison’’ exons, introducing PTCs predicted to induce NMD. (a)
Poison exon 1 is 98.6% identical at the base pair level between human and Xenopus and has transcriptional support in zebrafish. The UCSC
alignment of the zebrafish splice donor site has been corrected based on manual analysis, whereas the PTC used in this genome is found in the
subsequent exon. (b) In contrast, poison exon 2 cannot be aligned in any genomes beyond that of opossum. (c) Two AS acceptor sites are
found for this exon in human and mouse; the first (i) is limited to mammalian genomes, whereas the second (ii) exists (often with a ‘‘wobble’’
on the first base pair) in all genomes back to Xenopus (where there is transcriptional support). (d) The alternative final exon uses a splice site
found in mammals genomes only, although the STOP codon seen in mouse and other mammalian genomes is absent in apes; the human and
mouse CDS are thus significantly different.
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genomes and not beyond. Because human and mouse use
nonequivalent termination codons, this exon may represent
a genuine functional difference between the two species.
However, at this point, we reach the limits of what can be
extrapolated from an annotation-based analysis.
Conclusions
We have demonstrated the value of intensive manual
annotation for systematically describing and comparing
the AS content of vertebrate transcriptomes. We have
analyzed in detail the relationships between predicted
AS transcript functionality, TE association, and AS conser-
vation at the transcript and sequence levels. Although
each of these phenomena had been previously described
to some degree, ours is the first investigation to combine
each of these strands of analysis into a single picture
of gene evolution. Our analyses have focused on 1% of
the human genome, and we do not ‘‘scale up’’ our values
here due to sampling biases inherent in the creation of
the ENCODE pilot regions. However, we believe that
we have reported the most accurate values yet obtained
for these attributes at the gene level, achieving a level
of detail that approaches exhaustive within the limits
of current technology.
First, our comparison of human and mouse AS levels in-
dicates that although just 13.5% of human and 19.1% of
mouse transcripts are supported in both genomes, one
AS event is conserved per 1.9 multiexon genes. Although
conserved CDS transcripts outnumber NMD transcripts 5-
fold, we infer that gene regulation by NMD may be more
common than previously thought (conserved in 9% of hu-
man/mouse genes) and not particular to splicing factors. In
contrast, although our conservation-based approach alone
cannot confirm the functionality of several hundred spe-
cies-specific CDS, their annotation will be an essential first
step in the mining of incipient large-scale proteomics data
sets. Second, our results indicate that novel human and
mouse exons are created at similar rates from TE and
non-TE sequence. Third, we have shown that the patterns
of AS biotype association are different between conserved
and nonconserved AS events and between TE-linked and
nonlinked exons. Following this, our results indicate that
elevated sequence conservation is an attribute of specific
conserved AS events and more common to certain bio-
types, whereas the ST7 cassette exon indicates that ele-
vated conservation can also be coupled to TE-derived
AS events. Finally, we have demonstrated that at least
a quarter of conserved human/mouse AS events predate
the mammalian order and have shown for the first time
that this includes NMD-linked events. In combination,
these final two observations indicate that while AS events
have arisen throughout vertebrate evolution, elevated con-
servation (where observed) often appears at a significantly
later time. We speculate that AS events may undergo in-
creased purifying selection when they become coupled to
new regulatory processes (perhaps linked to tissue or de-
velopmental specificity), and that this may occur at any
point in evolution after the creation of the AS event.
In conclusion, the original paradigm for gene evolution
centers on the adaptive potential of amino acid changes in
a single protein molecule. In 2003, however, Modrek and
Lee presented a model in which AS represents an alternate
pathway for gene evolution, whereby novel functionality
can evolve without disruption to the main protein isoform
(Modrek and Lee 2003). Almost a decade later, we believe
that the contribution of AS to gene evolution remains
largely unexplored and still unappreciated; AS is routinely
ignored in studies considering the evolution of single genes.
In fact, we believe that AS may prove to be the more sig-
nificant form of ongoing gene evolution, particularly for
genes where the main protein product is under strong se-
lective constraint. For example, the 324 aa reference CDS of
human RBM39 differs from the mouse CDS at a single res-
idue, whereas the chicken CDS has just nine differences.
When we change our focus to the AS complement of
RBM39, however, a gene that appeared inert in terms of
evolution is seen to show dramatic change between spe-
cies. Overall, our work demonstrates that we cannot truly
understand the genome of a species until we have charac-
terized its AS complement and that our view of evolution
will remain incomplete until we understand how these pat-
terns have changed between species.
Supplementary Material
Supplementary files 1–5 are available at Molecular Biology
and Evolution online (http://www.mbe.oxfordjournals
.org/).
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